Anti-VEGF Drugs Boost Vision in Diabetic Eyes (CME/CE)
(MedPage Today) -- Relative effects of intravitreous aflibercept, bevacizumab, and ranibizumab depend on baseline visual acuity.
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Avastin | Diabetes | Endocrinology | Eyes | Lucentis | Ranibizumab Injection | Urology & Nephrology